Context: The United States Patent and Trademark Office (USPTO) has been implementing new Patent Trial and Appeal Board (PTAB) rules that deny or terminate inter partes review (IPR) unless the petitioner stipulates that no non-novelty or obviousness grounds will be raised in related litigation involving the same patents (October 16, 2025 ip fray article).
To Read The Full Story
Continue reading your article with a Membership
Counsel
Terumo was represented by Steptoe’s John Caracappa, Katherine Cappaert, Matthew Y. Sim, and D. Scott Chappell.
Haemonetics was represented by Proskauer Rose’s Erik Milch, Alan S. Teran, and Connor Villar.
Ford was represented by Brooks Kushman’s Andrew B. Turner, John S. LeRoy, Christopher Smith, and Kyle G. Konz.
AutoConnect was represented by Avantech Law’s Eric A. Zelepugas, Robert A. Conley, and William R. Woodford.